Stocks slide ahead of reports


Associated Press

NEW YORK

Edgy investors sent stocks lower Monday on Wall Street ahead of U.S. corporate earnings reports and amid more signs of instability in Europe.

The Dow Jones industrial average closed down 36.18 points at 12,736.29. It was the Dow’s third straight day of declines.

The Standard & Poor’s 500 index fell 2.22 points to 1,352.46 and the Nasdaq composite index fell 5.56 points to 2,931.77. Health care stocks rose the most, while stocks of materials companies fell the most.

Alcoa, one of the 30 stocks in the Dow, became the first major U.S. company to report second-quarter results after the market closed Monday.

The aluminum manufacturer beat the earnings per share estimates of Wall Street analysts by a penny, although revenue dropped due to weaker prices and pockets of declining demand in the slowing global economy.

Alcoa’s results are often seen as a harbinger for other major companies. So far, investor expectations are low. Wall Street forecasts a 1 percent decline in second-quarter earnings of S&P 500 companies compared with last year, according to Standard & Poor’s Capital IQ. That would be the first decline since the third quarter of 2009.

Kim Caughey-Forrest, senior equity analyst at Fort Pitt Capital Group, said many portfolio managers are afraid that this earnings season could bring bad surprises about stocks they’ve picked up earlier this year.

“It’s report card time,” Caughey-Forrest said.

AMD dropped 6 percent in after-hours trading after the semiconductor company unexpectedly released preliminary results following the market close. Revenue fell 11 percent from the previous quarter due to weak sales in China and Europe. The company had previously forecast revenue growth of 3 percent. The stock slumped 33 cents to $5.29.

Investors were also spooked Monday by news from Europe, where Spain’s borrowing costs rose as finance ministers from the euro countries gathered in Brussels to finalize a rescue package for Spain’s banks.

By using this site, you agree to our privacy policy and terms of use.

» Accept
» Learn More